Literature DB >> 16849885

B-type natriuretic peptide predicts postdischarge prognosis in elderly patients admitted due to cardiogenic pulmonary edema.

Roberto Valle1, Carolina Prevaldi, Alessandra D'Eri, Alessandra Fontebasso, Prospero Giovinazzo, Federica Noventa, Sabrina Barro, Emanuele Carbonieri, Loredano Milani, Nadia Aspromonte.   

Abstract

To examine the prognostic role of predischarge B-type natriuretic peptide (BNP) levels in elderly patients admitted to the hospital due to cardiogenic pulmonary edema, 203 patients consecutively admitted to the Heart Failure Unit of the Cardiology Department were retrospectively evaluated. The primary clinical end point selected was a combination of: 1) deaths; plus 2) readmissions to the hospital for heart failure in the 6 months after discharge. Thirty-one deaths (15.3%) and 44 readmissions for heart failure (21.7%) were recorded. Cox multivariate regression analysis confirmed that BNP cutoff values (identified on receiver-operated curve analysis) are the most accurate predictor of events. Hazard ratios (HRs) increased from the lowest, for BNP < or = 200 pg/mL (HR=1), through BNP 201-499 pg/mL (HR=2.3200; p=0.0174), to the highest, for BNP > or = 500 pg/mL (HR=3.6233; p=0.0009). This study demonstrates that BNP is useful in predischarge risk stratification of elderly patients with cardiogenic pulmonary edema.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16849885     DOI: 10.1111/j.1076-7460.2006.04830.x

Source DB:  PubMed          Journal:  Am J Geriatr Cardiol        ISSN: 1076-7460


  3 in total

1.  Admission, discharge, or change in B-type natriuretic peptide and long-term outcomes: data from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF) linked to Medicare claims.

Authors:  Robb D Kociol; John R Horton; Gregg C Fonarow; Eric M Reyes; Linda K Shaw; Christopher M O'Connor; G Michael Felker; Adrian F Hernandez
Journal:  Circ Heart Fail       Date:  2011-07-08       Impact factor: 8.790

2.  Effects of intermittent and long-term glucose-insulin-potassium infusion in patients with systolic heart failure.

Authors:  Nihat Kalay; Ibrahim Ozdogru; Ali Gul; Yilmaz Yucel; Yakup Cetinkaya; Mehmet Tugrul Inanc; Ali Dogan; Mehmet Gungor Kaya; Namýk Kemal Eryol
Journal:  Exp Clin Cardiol       Date:  2008

3.  B-type natriuretic peptide predicts 30-day readmission for heart failure but not readmission for other causes.

Authors:  Kelsey M Flint; Larry A Allen; Michael Pham; Paul A Heidenreich
Journal:  J Am Heart Assoc       Date:  2014-06-10       Impact factor: 5.501

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.